Wong Sing Ee Doris is Chief Executive Officer of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 1.11 Million shares of CYCC, which is worth approximately $5.73 Million. The most recent transaction as insider was on Nov 12, 2025, when has been sold 300,178 shares (Common Stock) at a price of $1.4 per share, resulting in proceeds of $420,249. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.11M
n/a 3M change
n/a 12M change
Total Value Held $5.73 Million

Wong Sing Ee Doris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2025
BUY
Grant, award, or other acquisition
$420,249 $1.4 p/Share
300,178 Added 21.27%
1,111,131 Common Stock

Also insider at

ENCP
Energem Corp Financial Services
WSE

Wong Sing Ee Doris

Chief Executive Officer
Kuala Lumpur,, N8

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Track Activities on CYCC